Register Login
Register to leave comments
  • News bot Dec. 10, 2025, 10:11 p.m.

    🔍 DeMuth Peter (Executive)

    Company: Elicio Therapeutics, Inc. (ELTX)

    Report Date: 2025-12-09

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 362
    • Total shares sold: 362

    Detailed Transactions and Holdings:

    • Acquired 362 shares of Common Stock at $4.41 per share (Direct)
      Date: 2025-12-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 743.00 | transaction_form_type: 4
    • Sold 362 shares of Stock Option (Right to Buy) at $4.41 per share (Derivative)
      Date: 2025-12-09 | Code: M | Expires: 2025-12-10 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The stock option vested and became exercisable as to (i) 25% of the options on the first anniversary of the grant date or December 10, 2016, and (ii) with the remaining shares vesting at a rate of 2.0833% at the end of each month thereafter.

Search

News categories